Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma-Reference-Cited by-同舟云学术

Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma

Published:2013-06-17 Issue:1 Volume:1291 Page:1-13
ISSN:0077-8923
Container-title:Annals of the New York Academy of Sciences
language:en
Short-container-title:Ann. N.Y. Acad. Sci.

Author:

Wolchok Jedd D.¹,Hodi F. Stephen²,Weber Jeffrey S.³,Allison James P.⁴,Urba Walter J.⁵,Robert Caroline⁶,O'Day Steven J.⁷,Hoos Axel⁸,Humphrey Rachel⁹,Berman David M.¹⁰,Lonberg Nils¹¹,Korman Alan J.¹¹

Affiliation:

1. Memorial Sloan‐Kettering Cancer Center New York New York

2. The Dana–Farber Cancer Institute Boston Massachusetts

3. H. Lee Moffitt Cancer Center and Research Institute Tampa Florida

4. MD Anderson Cancer Center Houston Texas

5. Earle A. Chiles Research Institute at Providence Cancer Center Portland Oregon

6. Institut Gustave Roussy Villejuif France

7. Beverly Hills Cancer Center Beverly Hills California

8. GlaxoSmithKline Collegeville Pennsylvania

9. MethylGene Inc., Montreal Quebec Canada

10. Bristol‐Myers Squibb Princeton New Jersey

11. Bristol‐Myers Squibb Redwood City California

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/nyas.12180

Reference91 articles.

1. American Cancer Society. Cancer Facts & Figures 2013.http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc‐036845.pdf

2. Cancer Statistics, 2010

3. Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials

4. Systematic Review of Medical Treatment in Melanoma: Current Status and Future Prospects

5. Diagnosis and Treatment of mela-noma Brain Metastasis: A Literature Review

Cited by 253 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BRAF/MEK inhibitor rechallenge in advanced melanoma patients;Cancer;2024-01-10

2. Molecular Mechanisms of Immune Checkpoints as an Immunotherapy Tool in Hematological Malignancies;Reference Module in Biomedical Sciences;2024

3. Current Status and Molecular Mechanisms of Resistance to Immunotherapy in Oral Malignant Melanoma;International Journal of Molecular Sciences;2023-12-08

4. A nanobody based ultrasensitive electrochemical biosensor for the detection of soluble CTLA-4 –A candidate biomarker for cancer development and progression;Biosensors and Bioelectronics;2023-12

5. XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4 monoclonal antibody, demonstrates tumor-growth inhibition and tumor-selective pharmacodynamics in mouse models of cancer;Journal for ImmunoTherapy of Cancer;2023-12